EC1456
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EC1456, covering 2019-02-07 to 2019-02-07. Get the full timeline:
Most recent: Clinical Trial Update: An Exploratory Study of the Folic Acid-tubulysin Conjugate EC1456 in Ovarian Cancer Subjects Undergoing Surgery [Phase 1]